These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19764383)

  • 1. [The Medical Products Agency: the tampon Ellen should be regulated as a pharmaceutical product].
    Bruse GW
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1995. PubMed ID: 19764383
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Ellen" fulfills the requirements].
    Wallter M
    Lakartidningen; 2009 Jul 8-21; 106(28-29):1840. PubMed ID: 19685631
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical devices; labeling for menstrual tampon for the "ultra" absorbency. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(202):62282-5. PubMed ID: 11503680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Final reply on vaginal tampons: unsuitable classification].
    Mårdh PA
    Lakartidningen; 2009 Jul 22-Aug 4; 106(30-31):1920. PubMed ID: 19739453
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statement of the Polish Gynecological Society Expert Group on the use of ellen probiotic tampon].
    Zespoł Ekspertów Polskiego Towarzystwa Ginekologicznego
    Ginekol Pol; 2012 Aug; 83(8):633-8. PubMed ID: 23342891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serious to declare that a product protects against genital infection].
    Mårdh PA
    Lakartidningen; 2009 Apr 22-28; 106(17):1197-8. PubMed ID: 19530433
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical devices; labeling for menstrual tampons; ranges of absorbency, change from "junior" to "light." Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Aug; 69(164):52170-1. PubMed ID: 15329983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety assessment of an ultra absorbency menstrual tampon.
    Hochwalt AE; Jones MB; Meyer SJ
    J Womens Health (Larchmt); 2010 Feb; 19(2):273-8. PubMed ID: 20109120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the standardization of intravaginal tampons for menstrual hygiene].
    Ito H; Shinozaki M; Kobatake M
    Eisei Shikenjo Hokoku; 1969; 87():74-6. PubMed ID: 5392245
    [No Abstract]   [Full Text] [Related]  

  • 10. [The licence drug policy of the Medical Drug Agency. Permitted use in special needs].
    Rastad JA; Klintberg K; Von Bahr C
    Lakartidningen; 1996 Nov; 93(47):4309-10. PubMed ID: 8984304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Board of Social Welfare, Institute for Public Health, Food Administration and Consumer Protection Department--what are all of you doing to control ineffective weight reducing products?].
    Förening S; Rössner S
    Lakartidningen; 1992 Nov; 89(48):4132-4. PubMed ID: 1461031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Separate drug control agencies united in a new, single organization].
    Forsberg B
    Lakartidningen; 1971 Apr; 68(15):1698-701. PubMed ID: 5577238
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Medical Product Agency sharpens its control. What is the consequence of bad trials?].
    Naeser SW; Nordlund S
    Lakartidningen; 1993 Dec; 90(51-52):4651-2. PubMed ID: 8264311
    [No Abstract]   [Full Text] [Related]  

  • 14. [The Medical Products Agency didn't "choose" Artrox].
    Rastad JA
    Lakartidningen; 2005 Oct 3-9; 102(40):2886. PubMed ID: 16255370
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lactobacilli and probiotics--the Devil lurks behind the details].
    Forsum U
    Lakartidningen; 2008 Oct 8-14; 105(41):2859-60. PubMed ID: 19009901
    [No Abstract]   [Full Text] [Related]  

  • 16. [Narcotic problem in 1976--debate, problem and measures].
    Hartelius J
    Lakartidningen; 1976 Nov; 73(46):3987-90. PubMed ID: 979469
    [No Abstract]   [Full Text] [Related]  

  • 17. [The responsibility for drug-induced damages in Sweden].
    Bengtsson B
    Nord Med; 1975 Apr; 90(4):113-5. PubMed ID: 1134910
    [No Abstract]   [Full Text] [Related]  

  • 18. Schedules of controlled substances; exempt anabolic steroid products. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2008 Mar; 73(52):14178-9. PubMed ID: 18464343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The drug game].
    Lakartidningen; 1975 Jun; 72(26):2731-2. PubMed ID: 1142903
    [No Abstract]   [Full Text] [Related]  

  • 20. [Report Nr 21 from the Committee on Side Effects of Drugs].
    Uvnäs B; Strandberg I
    Lakartidningen; 1974 Dec; 71(50):5135-6. PubMed ID: 4449279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.